Patty Hernandez, MD @pvhernandezmd X Profile

Patty Hernandez, MD

@pvhernandezmd

Followers

2K

Following

9K

Media

99

Statuses

1K

St. Louis, MO

Joined July 2020

Don't wanna be here? Send us removal request.

Patty Hernandez, MD

@pvhernandezmd

1 month

RT @AMPath: A FREE webinar at 1 p.m. Eastern on July 8 will feature fellows who recently passed their MGP board examination. Learn how they….

0

2

0

Patty Hernandez, MD

@pvhernandezmd

2 months

RT @AMPath: 🎉 Congratulations to our newest #AMPtutorials Social Media Challenge Winners! 🎉. 🏆 Chandler Ho, “T-Cell Receptor Gene Rearrange….

0

3

0

Patty Hernandez, MD

@pvhernandezmd

4 months

PIK3CA tweetorial. This educational resource does not constitute. Medical or legal advice and is not intended for use in the diagnosis or treatment of individual conditions. #AMPtutorials.

0

3

Patty Hernandez, MD

@pvhernandezmd

4 months

PIK3CA tweetorial. Alpelisib and capivasertib, when combined with the selective estrogen degraded, fulvestrant, as well as inavolisib inhibitor combination with both fulvestrant and palbociclib are FDA approved/ NCCN recommended therapies . #AMPtutorials

3

0

3

Patty Hernandez, MD

@pvhernandezmd

4 months

PIK3CA tweetorial. Many clinical laboratories now utilize targeted next-generation sequencing (NGS) assays for PIK3CA testing. #AMPtutorials

1

0

3

Patty Hernandez, MD

@pvhernandezmd

4 months

PIK3CA tweetorial . The majority of hotspot variants in the gene PIK3CA are in the helical and kinase domains. #AMPtutorials

1

0

3

Patty Hernandez, MD

@pvhernandezmd

4 months

PIK3CA tweetorial . The PIK3CA variants can be associated with malignancies and PIK3CA-Related Overgrowth Syndrome (PROS). #AMPtutorials

1

0

3

Patty Hernandez, MD

@pvhernandezmd

4 months

PIK3CA tweetorial (🧵 1/6). The PIK3CA gene encodes the p110-alpha catalytic subunit of PIK3 pathway; pathogenic/ oncogenic variants often result in overactivation of this pathway (gain-of-function). #AMPtutorials #Molpath #path2path #PathX

1

10

22

Patty Hernandez, MD

@pvhernandezmd

8 months

Great @WUSTL Genomics and Molecular Pathology division representation! 🧬.#AMPath24 @AMPath

0

1

16

Patty Hernandez, MD

@pvhernandezmd

8 months

Grateful for the opportunity to present at Early Bird session #AMPath24 @AMPath

0

1

17

Patty Hernandez, MD

@pvhernandezmd

11 months

RT @KurtSchaberg: I finished adding some notes on basic molecular pathology (for surgical pathologists) to my teaching website, "Kurt's Not….

0

87

0

Patty Hernandez, MD

@pvhernandezmd

1 year

I’m thrilled to announce that I passed boards! ✅

11

2

131

Patty Hernandez, MD

@pvhernandezmd

1 year

… and now, I am on my last day of residency 🥹.@washupathedu @wusm_pathology

6

1

52

Patty Hernandez, MD

@pvhernandezmd

1 year

RT @farnsworthcw: We are hiring! Looking for a clinical lab tech for my research lab. Let me know if you have any good leads! . https://t.co….

0

5

0

Patty Hernandez, MD

@pvhernandezmd

1 year

RT @studyrare: There are 2 techniques used for paternity testing👨‍👩‍👦🧪:.PCR: "Papa Can't Run".RFLP: "Real Fathers Leave Prints". PCR is per….

0

7

0

Patty Hernandez, MD

@pvhernandezmd

1 year

@DibsonG.

0

Patty Hernandez, MD

@pvhernandezmd

1 year

- Brazilians in #Pathology .- Brazilians in #PathInformatics.- And thrilled to be recipients of the Becich-Friedman Distinguished Presentation .@wusm_pathology @washupathedu @l_pathology #LatinX

2

1

12

Patty Hernandez, MD

@pvhernandezmd

1 year

Now the complete @wusm_pathology #PathInformatics team at Association for Pathology Informatics Summit 2024!.#PathX @washupathedu

0

14

Patty Hernandez, MD

@pvhernandezmd

1 year

WashU #Pathology #Informatics team at the Association for Pathology Informatics Summit 2024!.#PathX #PathTwitter #PathInformatics .@wusm_pathology @washupathedu

0

23

Patty Hernandez, MD

@pvhernandezmd

1 year

Must-read article on somatic mosaicism written by @ZitaHubler and @Yang_Cao_FACMG .@washupathedu @wusm_pathology . Somatic Mosaicism across Human Tissues (SMaHT) Network, a SMART Investment?

0

2

13